SunWay Biotech Co Valeur comptable par action

Que fait SunWay Biotech Co ? SunWay Biotech Co Ltd is a pharmaceutical company based in Taipei City, Taiwan. The company went public on January 18, 2021, with its ticker listed as 1271.TWO and ISIN TW0001271005. SunWay Biotech focuses on the research, development, manufacture, and sale of health food products, particularly those derived from red yeast. The company's primary products include Lactobacillus paracasei subsp. paracasei NTU 101 and Monascus purpureus NTU 568, which are marketed for their health benefits. These products are designed to support digestive health, improve the bacterial ecology of the digestive tract, regulate immunity, and address allergies. SunWay Biotech operates in both domestic and international markets, distributing its products globally. The company's website is https://sunway.cc/, where further information about its offerings can be found. SunWay Biotech is categorized under the Health Care sector, specifically within the Pharmaceuticals industry. The company's business model centers on the production and sale of health food supplements, emphasizing natural ingredients and their functional benefits. It does not provide information on specific founding year, key personnel, or financial figures beyond its IPO date. The company's activities are strictly limited to the development and distribution of health food products without mention of additional services or product lines. SunWay Biotech Co est l'une des entreprises les plus populaires sur Eulerpool.